Prostate CancerNCT05886751
Randomized Trial of Trust in Online Videos About Prostate Cancer
A study testing Black Doctor Screening Video, White Doctor Screening Video and Black Patient Screening Video in people with Prostate Cancer, run by NYU Langone Health at 1 site in United States.
Trial summary
The study team will evaluate the impact of video characteristics on health consumers' trust in online videos. Participants will be randomized to watch a video by one of four speakers about prostate cancer screening or clinical trials and complete a questionnaire (approximately 15 minutes total). Read more about this study
- Who is it for?
- Ages 40 years and olderHealthy volunteers can take part
- Conditions the study is for
- Prostate Cancer
- What is being tested?
- Black Doctor Screening Video, White Doctor Screening Video and Black Patient Screening Video
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 3,649 participants
- Where
- 1 siteUnited States
- Study dates
- 18 Aug 2021to 7 Jan 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- US adult age 40+
- Enrolled in Dynata online survey panel
Who cannot join
- Children
- Individuals living outside the U.S.
Trial locations and contacts
1 site in 1 country.
About this study
The study team will evaluate the impact of video characteristics on health consumers' trust in online videos. Participants will be randomized to watch a video by one of four speakers about prostate cancer screening or clinical trials and complete a questionnaire (approximately 15 minutes total).
- Conditions
- Prostate Cancer
- Being tested
- Black Doctor Screening Video, White Doctor Screening Video, Black Patient Screening Video, White Patient Screening Video, Black Doctor Clinical Trials Video
- Keywords
- Trust
- Medical subject headings
- Prostatic Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Black Doctor Screening VideoOther
Participants will view an online video with a Black doctor speaking about prostate cancer screening.
White Doctor Screening VideoOther
Participants will view an online video with a White doctor speaking about prostate cancer screening.
Black Patient Screening VideoOther
Participants will view an online video with a Black patient speaking about prostate cancer screening.
White Patient Screening VideoOther
Participants will view an online video with a White patient speaking about prostate cancer screening.
Black Doctor Clinical Trials VideoOther
Participants will view an online video with a Black doctor speaking about prostate cancer clinical trials.
White Doctor Clinical Trials VideoOther
Participants will view an online video with a White doctor speaking about prostate cancer clinical trials.
Black Patient Clinical Trials VideoOther
Participants will view an online video with a Black patient speaking about prostate cancer clinical trials.
White Patient Clinical Trials VideoOther
Participants will view an online video with a White patient speaking about prostate cancer clinical trials.
| Study group | Role | What they receive |
|---|---|---|
| Video About Screening with Black Doctor | Experimental | Not described Receives: Other: Black Doctor Screening Video |
| Video About Screening with White Doctor | Experimental | Not described Receives: Other: White Doctor Screening Video |
| Video About Screening with Black Patient | Experimental | Not described Receives: Other: Black Patient Screening Video |
| Video About Screening with White Patient | Experimental | Not described Receives: Other: White Patient Screening Video |
| Video about Clinical Trials with Black Doctor | Experimental | Not described Receives: Other: Black Doctor Clinical Trials Video |
| Video about Clinical Trials with White Doctor | Experimental | Not described Receives: Other: White Doctor Clinical Trials Video |
| Video about Clinical Trials with Black Patient | Experimental | Not described Receives: Other: Black Patient Clinical Trials Video |
| Video about Clinical Trials with White Patient | Experimental | Not described Receives: Other: White Patient Clinical Trials Video |
What is being measured
The primary outcome is the main question the study is designed to answer.
Level of Trust in the Video
Trust will be reported as a score on a Likert scale and asked as the following question: How much do you trust the information in the video? The total range of score is 1-4, where (1) trust the information completely, (2) trust most of the information, (3) trust some of the information, (4) do not trust the information
Measured: Visit 1 (Day 1)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Jun 2023
- Study start18 Aug 2021
- Primary completion7 Jan 2022
- Study completion7 Jan 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Prostate CancerStudies of the same condition, open and under way.
- More trials run by NYU Langone HealthThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 3,649 participants (actual)
Sponsor and investigators
- Lead sponsor
- NYU Langone Health
- Sponsor type
- University, hospital or other
- Collaborators
- United States Department of Defense
- Responsible party
- Sponsor
- Investigators
- Stacy Loeb, MD, MSc, PhD(hc), Principal investigator, NYU Langone Health
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05886751
- Sponsor's protocol ID
- 20-00540
- Status last verified
- Apr 2024
- First submitted
- 24 May 2023
- Last updated
- 26 Apr 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Individual participant data needed for the proposed biomedical research use according to data use agreement from both parties will be shared.
Publications
Loeb S, Ravenell JE, Gomez SL, Borno HT, Siu K, Sanchez Nolasco T, Byrne N, Wilson G, Griffith DM, Crocker R, Sherman R, Washington SL 3rd, Langford AT. The Effect of Racial Concordance on Patient Trust in Online Videos About Prostate Cancer: A Randomized Clinical Trial. JAMA Netw Open. 2023 Jul 3;6(7):e2324395. doi: 10.1001/jamanetworkopen.2023.24395.
PubMed 37466938
Study at a glance
From the registry record, last updated by the sponsor on 26 Apr 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Randomized Trial of Trust in Online Videos About Prostate Cancer
- ClinicalTrials.gov ID
- NCT05886751
- Acronym / sponsor ID
- 20-00540
- Conditions
- Prostate Cancer
- Keywords
- Trust
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 3,649 participants (actual)
- Lead sponsor
- NYU Langone HealthUniversity, hospital or other
- Collaborators
- United States Department of Defense
- Study start
- 18 Aug 2021 (actual)
- Primary completion
- 7 Jan 2022 (actual)
- Study completion
- 7 Jan 2022 (actual)
- First posted
- 2 Jun 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The study team will evaluate the impact of video characteristics on health consumers' trust in online videos. Participants will be randomized to watch a video by one of four speakers about prostate cancer screening or clinical trials and complete a questionnaire (approximately 15 minutes total).
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 8
| Arm | Type | Receives |
|---|---|---|
| Video About Screening with Black Doctor | Experimental | Other: Black Doctor Screening Video |
| Video About Screening with White Doctor | Experimental | Other: White Doctor Screening Video |
| Video About Screening with Black Patient | Experimental | Other: Black Patient Screening Video |
| Video About Screening with White Patient | Experimental | Other: White Patient Screening Video |
| Video about Clinical Trials with Black Doctor | Experimental | Other: Black Doctor Clinical Trials Video |
| Video about Clinical Trials with White Doctor | Experimental | Other: White Doctor Clinical Trials Video |
| Video about Clinical Trials with Black Patient | Experimental | Other: Black Patient Clinical Trials Video |
| Video about Clinical Trials with White Patient | Experimental | Other: White Patient Clinical Trials Video |
Who may qualify
- Ages
- 40 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- US adult age 40+
- Enrolled in Dynata online survey panel
Key exclusion criteria (2 listed)
- Children
- Individuals living outside the U.S.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Black Doctor Screening VideoParticipants will view an online video with a Black doctor speaking about prostate cancer screening. | Other | Video About Screening with Black Doctor |
| White Doctor Screening VideoParticipants will view an online video with a White doctor speaking about prostate cancer screening. | Other | Video About Screening with White Doctor |
| Black Patient Screening VideoParticipants will view an online video with a Black patient speaking about prostate cancer screening. | Other | Video About Screening with Black Patient |
| White Patient Screening VideoParticipants will view an online video with a White patient speaking about prostate cancer screening. | Other | Video About Screening with White Patient |
| Black Doctor Clinical Trials VideoParticipants will view an online video with a Black doctor speaking about prostate cancer clinical trials. | Other | Video about Clinical Trials with Black Doctor |
| White Doctor Clinical Trials VideoParticipants will view an online video with a White doctor speaking about prostate cancer clinical trials. | Other | Video about Clinical Trials with White Doctor |
| Black Patient Clinical Trials VideoParticipants will view an online video with a Black patient speaking about prostate cancer clinical trials. | Other | Video about Clinical Trials with Black Patient |
| White Patient Clinical Trials VideoParticipants will view an online video with a White patient speaking about prostate cancer clinical trials. | Other | Video about Clinical Trials with White Patient |
Primary outcome
Level of Trust in the Video
Time frame: Visit 1 (Day 1)
Trust will be reported as a score on a Likert scale and asked as the following question: How much do you trust the information in the video? The total range of score is 1-4, where (1) trust the information completely, (2) trust most of the information, (3) trust some of the information, (4) do not trust the information
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Apr 2024.
- Results publication: PubMed 37466938Loeb S, Ravenell JE, Gomez SL, Borno HT, Siu K, Sanchez Nolasco T, Byrne N, Wilson G, Griffith DM, Crocker R, Sherman R, Washington SL 3rd, Langford AT. The Effect of Racial Concordance on Patient Trust in Online Videos About Prostate Cancer: A Randomized Clinical Trial. JAMA Netw Open. 2023 Jul 3;6(7):e2324395. doi: 10.1001/jamanetworkopen.2023.24395.
- Individual participant dataSharing planned: Yes. Individual participant data needed for the proposed biomedical research use according to data use agreement from both parties will be shared.
Related trials for Prostate Cancer
Active, not recruiting
Streamlined Geriatric and Oncological Evaluation Based On IC Technology
Breast Cancer, Comorbidities and Coexisting Conditions
Active, not recruitingObservational study
MRI Fusion Biopsy vs. Micro-Ultrasound Guided Biopsy
Prostate Cancer
Enrolling by invitationObservational study
Natural History Study of Early Life Exposures in Agriculture (ELEA)
Prostate Cancer, Leukemia
Not yet recruitingPhase 1/2
STAR0602 With Nivolumab in Non Small Cell Lung Cancer and in Metastatic Castrate-Resistant Prostate Cancer, and STAR0602 Alone in Thymic Carcinoma
NSCLC, Non-Small Cell Lung Cancer
Recruiting
Rehabilitation and Sex Therapy to Optimize Recovery After Prostate Cancer Treatment
Prostate Cancer, Urinary Incontinence
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Stacy Loeb, MD, MSc, PhD(hc) principal investigator
NYU Langone Health
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Black Doctor Screening Video, White Doctor Screening Video and Black Patient Screening Video in people with Prostate Cancer, run by NYU Langone Health at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 26 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Level of Trust in the Video (time frame: Visit 1 (Day 1)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05886751, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Apr 2024.